EarliPoint Assessment

EarliPoint Assessment is an FDA 510(k)-cleared medical device (K253442) manufactured by Earlitec Diagnostics. This device is classified under the Neurology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on March 4, 2026. Regulation: 8.